| Ident. | Authors (with country if any) | Title |
|---|
| 000019 |
Thomas Mcdonnell [Royaume-Uni] ; Chris Wincup [Royaume-Uni] ; Ina Buchholz [Allemagne] ; Charis Pericleous [Royaume-Uni] ; Ian Giles [Royaume-Uni] ; Vera Ripoll [Royaume-Uni] ; Hannah Cohen [Royaume-Uni] ; Mihaela Delcea [Allemagne] ; Anisur Rahman [Royaume-Uni] | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
| 000142 |
Leo Swadling [Royaume-Uni] ; Laura J. Pallett [Royaume-Uni] ; Mariana O. Diniz [Royaume-Uni] ; Josephine M. Baker [Royaume-Uni] ; Oliver E. Amin [Royaume-Uni] ; Kerstin A. Stegmann [Royaume-Uni] ; Alice R. Burton [Royaume-Uni] ; Nathalie M. Schmidt [Royaume-Uni] ; Anna Jeffery-Smith [Royaume-Uni] ; Nekisa Zakeri [Royaume-Uni] ; Kornelija Suveizdyte [Royaume-Uni] ; Farid Froghi [Royaume-Uni] ; Giuseppe Fusai [Royaume-Uni] ; William M. Rosenberg [Royaume-Uni] ; Brian R. Davidson [Royaume-Uni] ; Anna Schurich [Royaume-Uni] ; A. Katharina Simon [Royaume-Uni] ; Mala K. Maini [Royaume-Uni] | Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence |
| 000178 |
Didier Raoult [France] ; Alimuddin Zumla [Royaume-Uni] ; Franco Locatelli [Italie] ; Giuseppe Ippolito [Italie] ; Guido Kroemer [France] | Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |
| 000197 |
Antoine Dewitte [France] ; Julien Villeneuve [Royaume-Uni] ; Sébastien Lepreux [France] ; Marion Bouchecareilh [France] ; Xavier Gauthereau [France] ; Claire Rigothier [France] ; Christian Combe [France] ; Alexandre Ouattara [France] ; Jean Ripoche [France] | CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine |
| 000224 |
Alaa Riezk [Royaume-Uni] ; John G. Raynes [Royaume-Uni] ; Vanessa Yardley [Royaume-Uni] ; Sudaxshina Murdan [Royaume-Uni] ; Simon L. Croft [Royaume-Uni] | Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicanaIn Vitro |
| 000254 |
Philippa M. Wells [Royaume-Uni] ; Frances M. K. Williams [Royaume-Uni] ; M. L. Matey-Hernandez [Royaume-Uni] ; Cristina Menni [Royaume-Uni] ; Claire J. Steves [Royaume-Uni] | ‘RA and the microbiome: do host genetic factors provide the link? |
| 000344 |
Cindy S. Chu [Thaïlande, Royaume-Uni] ; Germana Bancone [Thaïlande, Royaume-Uni] ; Nay Lin Soe [Thaïlande] ; Verena I. Carrara [Thaïlande, Suisse] ; Gornpan Gornsawun [Thaïlande] ; François Nosten [Thaïlande, Royaume-Uni] | The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis |
| 000379 |
Michela Mazzon [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Targeting viral entry as a strategy for broad-spectrum antivirals |
| 000391 |
Mercedes Segovia [Uruguay] ; Sofia Russo [Uruguay] ; Mathias Jeldres [Uruguay] ; Yamil D. Mahmoud [Argentine] ; Valentina Perez [Uruguay] ; Maite Duhalde [Uruguay] ; Pierre Charnet [France] ; Matthieu Rousset [France] ; Sabina Victoria [Uruguay] ; Florencia Veigas [Argentine] ; Cédric Louvet [France] ; Bernard Vanhove [France] ; R. Andrés Floto [Royaume-Uni] ; Ignacio Anegon [France] ; Maria Cristina Cuturi [France] ; M. Romina Girotti [Argentine] ; Gabriel A. Rabinovich [Argentine] ; Marcelo Hill [Uruguay] | Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation |
| 000468 |
Jennifer Bryant [Royaume-Uni] ; Nikolaos Batis [Royaume-Uni] ; Anna Clara Franke [Royaume-Uni] ; Gabriella Clancey [Royaume-Uni] ; Margaret Hartley [Royaume-Uni] ; Gordon Ryan [Royaume-Uni] ; Jill Brooks [Royaume-Uni] ; Andrew D. Southam [Royaume-Uni] ; Nicholas Barnes [Royaume-Uni] ; Joanna Parish [Royaume-Uni] ; Sally Roberts [Royaume-Uni] ; Farhat Khanim [Royaume-Uni] ; Rachel Spruce [Royaume-Uni] ; Hisham Mehanna [Royaume-Uni] | Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma |
| 000469 |
Marina Bacci [Italie] ; Nicla Lorito [Italie] ; Luigi Ippolito [Italie] ; Matteo Ramazzotti [Italie] ; Simone Luti [Italie] ; Simone Romagnoli [Italie] ; Matteo Parri [Italie] ; Francesca Bianchini [Italie] ; Federica Cappellesso [Belgique] ; Federico Virga [Belgique, Italie] ; Qiong Gao [Royaume-Uni] ; Bruno M. Sim Es [Royaume-Uni] ; Elisabetta Marangoni [France] ; Lesley-Ann Martin [Royaume-Uni] ; Giuseppina Comito [Italie] ; Manuela Ferracin [Italie] ; Elisa Giannoni [Italie] ; Massimiliano Mazzone [Belgique] ; Paola Chiarugi [Italie] ; Andrea Morandi [Italie] | Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer |
| 000695 |
Valentina Pucino [Royaume-Uni] ; Michelangelo Certo [Royaume-Uni] ; Vinay Bulusu [Royaume-Uni] ; Danilo Cucchi [Royaume-Uni] ; Katriona Goldmann [Royaume-Uni] ; Elena Pontarini [Royaume-Uni] ; Robert Haas [Royaume-Uni] ; Joanne Smith [Royaume-Uni] ; Sarah E. Headland [Royaume-Uni] ; Kevin Blighe [Royaume-Uni] ; Massimiliano Ruscica [Italie] ; Frances Humby [Royaume-Uni] ; Myles J. Lewis [Royaume-Uni] ; Jurre J. Kamphorst [Royaume-Uni] ; Michele Bombardieri [Royaume-Uni] ; Costantino Pitzalis [Royaume-Uni] ; Claudio Mauro [Royaume-Uni] | Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring |
| 000748 |
Beth I. Wallace [États-Unis] ; Chelsea A. Harris ; Lu Wang ; Mochuan Liu ; Jung-Sheng Chen ; Chang-Fu Kuo [Royaume-Uni] ; Kevin C. Chung | Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease |
| 000749 |
M. J. Cuadrado [Royaume-Uni] ; I. Calatayud [Royaume-Uni] ; M. Urquizu-Padilla [Royaume-Uni] ; S. Wijetilleka [Royaume-Uni] ; S. Kiani-Alikhan [Royaume-Uni] ; M. Y. Karim [Qatar] | Immunoglobulin abnormalities are frequent in patients with lupus nephritis |
| 000759 |
Rebecca Carter [Royaume-Uni] ; Azadeh Cheraghchi-Bashi [Royaume-Uni] ; Adam Westhorpe [Royaume-Uni] ; Sheng Yu [Royaume-Uni] ; Yasmin Shanneik [Royaume-Uni] ; Elena Seraia [Royaume-Uni] ; Djamila Ouaret [Royaume-Uni] ; Yasuhiro Inoue [Japon] ; Catherine Koch [États-Unis] ; Jenny Wilding [Royaume-Uni] ; Daniel Ebner [Royaume-Uni] ; Anderson J. Ryan [Royaume-Uni] ; Francesca M. Buffa [Royaume-Uni] ; Ricky A. Sharma [Royaume-Uni] | Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
|
| 000774 |
Peter. C. Taylor [Royaume-Uni] ; Alejandro Balsa Criado ; Anne-Barbara Mongey ; Jerome Avouac ; Hubert Marotte ; Rudiger B. Mueller | How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy |
| 000786 |
David Kuo [États-Unis] ; Jennifer Ding [États-Unis] ; Ian S. Cohn [États-Unis] ; Fan Zhang [États-Unis] ; Kevin Wei [États-Unis] ; Deepak A. Rao [États-Unis] ; Cristina Rozo [États-Unis] ; Upneet K. Sokhi [États-Unis] ; Sara Shanaj [États-Unis] ; David J. Oliver [États-Unis] ; Adriana P. Echeverria [États-Unis] ; Edward F. Dicarlo [États-Unis] ; Michael B. Brenner [États-Unis] ; Vivian P. Bykerk [États-Unis] ; Susan M. Goodman [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Gunnar R Tsch [Suisse, États-Unis] ; Lionel B. Ivashkiv [États-Unis] ; Laura T. Donlin [États-Unis] | HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness |
| 000852 |
Peter C. Taylor ; Didier Saurigny [Royaume-Uni] ; Jiri Vencovsky [République tchèque] ; Tsutomu Takeuchi [Japon] ; Tadashi Nakamura [Japon] ; Galina Matsievskaia [Russie] ; Barbara Hunt [États-Unis] ; Thomas Wagner [Suisse] ; Bernard Souberbielle [Royaume-Uni] | Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial |
| 000868 |
Katja B. Kostelnik [Royaume-Uni] ; Amy Barker [Royaume-Uni] ; Christopher Schultz [Royaume-Uni] ; Tom P. Mitchell [Royaume-Uni] ; Vinothini Rajeeve [Royaume-Uni] ; Ian J. White [Royaume-Uni] ; Michel Aurrand-Lions [France] ; Sussan Nourshargh [Royaume-Uni] ; Pedro Cutillas [Royaume-Uni] ; Thomas D. Nightingale [Royaume-Uni] | Dynamic trafficking and turnover of JAM-C is essential for endothelial cell migration |
| 000968 |
Tommy Weiss-Sadan ; Gal Itzhak ; Farnusch Kaschani [Allemagne] ; Zhanru Yu [Royaume-Uni] ; Mohamed Mahameed ; Adi Anaki ; Yael Ben-Nun ; Emmanuelle Merquiol ; Boaz Tirosh ; Benedikt Kessler [Royaume-Uni] ; Markus Kaiser [Allemagne] ; Galia Blum | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation |
| 000B71 |
Mariam Al-Attar [Royaume-Uni] ; Rachel Gorodkin [Royaume-Uni] | 9. Hypomyopathic dermatomyositis complicated by mannose-binding lectin deficiency |
| 000B78 |
Elizabeth Clarke [Royaume-Uni] ; Marie Clegg [Royaume-Uni] ; Heather Green [Royaume-Uni] ; Pippa Watson [Royaume-Uni] | 24. Chronic inflammatory arthritis in the context of cystic fibrosis |
| 000C38 |
Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour] | Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer. |
| 000D81 |
Shino Magaki [États-Unis] ; Edward Chang ; Robert R. Hammond ; Isaac Yang ; Ian R. A. Mackenzie [Canada] ; Benedict T. Chou ; Soo I. Choi ; Joanna C. Jen ; Whitney B. Pope ; David A. Bell [Canada] ; Harry V. Vinters [États-Unis] | Two cases of rheumatoid meningitis |
| 000E88 |
Andrew Bush [Royaume-Uni] ; Steve Cunningham [Royaume-Uni] ; Jacques De Blic [France] ; Angelo Barbato [Italie] ; Annick Clement [France] ; Ralph Epaud [France] ; Meike Hengst [Allemagne] ; Nural Kiper [Turquie] ; Andrew G. Nicholson [Royaume-Uni] ; Martin Wetzke [Allemagne] ; Deborah Snijders [Italie] ; Nicolaus Schwerk [Allemagne] ; Matthias Griese [Allemagne] | European protocols for the diagnosis and initial treatment of interstitial lung disease in children. |
| 000F59 |
Fatma E. Mohamed [Royaume-Uni, Égypte] ; Rajai M. Al-Jehani [Royaume-Uni] ; Shane S. Minogue [Royaume-Uni] ; Fausto Andreola [Royaume-Uni] ; Alison Winstanley [Royaume-Uni] ; Steven W. M. Olde Damink [Royaume-Uni] ; Abeba Habtesion [Royaume-Uni] ; Massimo Malag [Royaume-Uni] ; Nathan Davies [Royaume-Uni] ; Tu Vinh Luong [Royaume-Uni] ; Amar P. Dhillon [Royaume-Uni] ; Rajeshwar P. Mookerjee [Royaume-Uni] ; Dipok K. Dhar [Royaume-Uni] ; Rajiv Jalan [Royaume-Uni] | Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma |
| 000F63 |
Ruth O'Reilly [Royaume-Uni] ; David Kilner [Royaume-Uni] ; Michael Ashworth [Royaume-Uni] ; Paul Aurora [Royaume-Uni] | Diffuse lung disease in infants less than 1 year of age: Histopathological diagnoses and clinical outcome |
| 000F77 |
R. J. Powell [Royaume-Uni] ; S. C. Leech [Royaume-Uni] ; S. Till [Royaume-Uni] ; P. A. J. Huber [Royaume-Uni] ; S. M. Nasser [Royaume-Uni] ; A. T. Clark [Royaume-Uni] | BSACI guideline for the management of chronic urticaria and angioedema |
| 000F78 |
Lorenzo Galluzzi [France, Italie] ; Federico Pietrocola [France] ; José Manuel Bravo-San Pedro [France] ; Ravi K. Amaravadi [États-Unis] ; Eric H. Baehrecke [États-Unis] ; Francesco Cecconi [Danemark, Italie] ; Patrice Codogno [France] ; Jayanta Debnath [États-Unis] ; David A. Gewirtz [États-Unis] ; Vassiliki Karantza [États-Unis] ; Alec Kimmelman [États-Unis] ; Sharad Kumar [Australie] ; Beth Levine [États-Unis] ; Maria Chiara Maiuri [France] ; Seamus J. Martin [Irlande (pays)] ; Josef Penninger [Autriche] ; Mauro Piacentini [Italie] ; David C. Rubinsztein [Royaume-Uni] ; Hans-Uwe Simon [Suisse] ; Anne Simonsen [Norvège] ; Andrew M. Thorburn [États-Unis] ; Guillermo Velasco [Espagne] ; Kevin M. Ryan [Royaume-Uni] ; Guido Kroemer [France] | Autophagy in malignant transformation and cancer progression |
| 000F80 |
Mira Merashli [Royaume-Uni] ; Mohammad Hassan A. Noureldine [Liban] ; Imad Uthman [Liban] ; Munther Khamashta [Royaume-Uni] | Antiphospholipid syndrome: an update |
| 001021 |
Lisa Jolly [Royaume-Uni] ; Anastasios Stavrou [Royaume-Uni] ; Gilles Vanderstoken [Canada] ; Victoria A. Meliopoulos [États-Unis] ; Anthony Habgood [Royaume-Uni] ; Amanda L. Tatler [Royaume-Uni] ; Joanne Porte [Royaume-Uni] ; Alan Knox [Royaume-Uni] ; Paul Weinreb [États-Unis] ; Shelia Violette [États-Unis] ; Tracy Hussell [Royaume-Uni] ; Martin Kolb [Canada] ; Martin R. Stampfli [Canada] ; Stacey Schultz-Cherry [États-Unis] ; Gisli Jenkins [Royaume-Uni] | Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation. |
| 001029 |
Sivan M. Bokobza [Royaume-Uni] ; Yanyan Jiang ; Anika M. Weber ; Aoife M. Devery ; Anderson J. Ryan [Royaume-Uni] | Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells. |
| 001043 |
John K F. Wong [Royaume-Uni] ; Ross Nortley [Royaume-Uni] ; Thomasin Andrews [Royaume-Uni] ; David D'Cruz [Royaume-Uni] | Psychiatric manifestations of primary Sjögren's syndrome: a case report and literature review |
| 001048 |
Michael Williamson [Royaume-Uni] ; Colin Wallis [Royaume-Uni] | Ten‐year follow up of hydroxychloroquine treatment for ABCA3 deficiency |
| 001077 |
John O. Suberu [Royaume-Uni] ; Isolda Romero-Canel N [Royaume-Uni] ; Neil Sullivan [Royaume-Uni] ; Alexei A. Lapkin [Royaume-Uni] ; Guy C. Barker [Royaume-Uni] | Comparative Cytotoxicity of Artemisinin and Cisplatin and Their Interactions with Chlorogenic Acids in MCF7 Breast Cancer Cells |
| 001133 |
Christopher J M. Whitty [Royaume-Uni] ; Peter L. Chiodini [Royaume-Uni] ; David G. Lalloo [Royaume-Uni] | Investigation and treatment of imported malaria in non-endemic countries |
| 001136 |
Simona Turcu [Royaume-Uni] ; Emma Ashton [Royaume-Uni] ; Lucy Jenkins [Royaume-Uni] ; Atul Gupta [Royaume-Uni] ; Quen Mok [Royaume-Uni] | Genetic testing in children with surfactant dysfunction |
| 001141 |
Cameron Alexander [Royaume-Uni] ; Francisco Fernandez Trillo [Royaume-Uni] | CHAPTER 10 - Bioresponsive Polyplexes and Micelleplexes |
| 001166 |
Joonas H. Kauppila [Finlande] ; Tuomo J. Karttunen [Finlande] ; Juha Saarnio [Finlande] ; Pia Nyberg [Finlande] ; Tuula Salo [Finlande] ; David E. Graves [États-Unis] ; Petri P. Lehenkari [Finlande] ; Katri S. Selander [États-Unis] | Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion |
| 001169 |
Mahmoud Dastoori [Royaume-Uni] ; Stefano Fedele [Royaume-Uni] ; Jair C. Leao [Royaume-Uni, Brésil] ; Stephen R. Porter [Royaume-Uni] | Sarcoidosis – a clinically orientated review |
| 001182 |
Beverley J. Hunt [Royaume-Uni] ; Rowena R. Thomas-Dewing ; Kate Bramham [Royaume-Uni] ; Sebastian B. Lucas | Preventing maternal deaths due to acquired thrombotic thrombocytopenic purpura |
| 001216 |
D. A. Pappas [États-Unis] ; M. Hooper ; G. Reed ; Y. Shan ; D. Wenkert ; J. Zhang [Royaume-Uni] ; J. Greenberg [États-Unis] ; J. Curtis [Royaume-Uni] | FRI0108 Risk for herpes zoster after treatment with biologic and synthetic disease modifying agents for rheumatoid arthritis |
| 001229 |
Farzaneh Salem [Royaume-Uni] ; Amin Rostami-Hodjegan [Royaume-Uni] ; Trevor N. Johnson [Royaume-Uni] | Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature |
| 001232 |
J. Zhang ; Q. L. Zhu ; P. Huang [République populaire de Chine] ; Q. Yu ; Z. H. Wang ; P. R. Cooper [Royaume-Uni] ; A. J. Smith [Royaume-Uni] ; W. He [République populaire de Chine] | CpG ODN‐induced matrix metalloproteinase‐13 expression is mediated via activation of the ERK and NF‐κB signalling pathways in odontoblast cells |
| 001312 |
F. Mohamed [Royaume-Uni] ; D. Dhar [Royaume-Uni] ; N. Shah [Royaume-Uni] ; N. Davies [Royaume-Uni] ; A. Habtesion [Royaume-Uni] ; T. Luong [Royaume-Uni] ; A. Winstanley [Royaume-Uni] ; A P Dhillon [Royaume-Uni] ; R. Mookerjee [Royaume-Uni] ; R. Jalan [Royaume-Uni] | PMO-092 TLR7 expression is increased in hepatocellular cancer (HCC) and its modulation is associated with alterations in tumour growth: a novel therapeutic target |
| 001313 |
F. Mohamed [Royaume-Uni] ; S. Minogue [Royaume-Uni] ; N. Shah [Royaume-Uni] ; N. Davies [Royaume-Uni] ; A. Habtesion [Royaume-Uni] ; T. Luong [Royaume-Uni] ; A. Winstanley [Royaume-Uni] ; A P Dhillon [Royaume-Uni] ; R. Mookerjee [Royaume-Uni] ; R. Jalan [Royaume-Uni] | PMO-091 TLR 9 inhibition: a novel target of therapy for primary liver cancer |
| 001317 |
Tia Hunjan [Royaume-Uni] ; Muzzafer Chaudery [Royaume-Uni] ; Ahsan Zaidi [Royaume-Uni] ; Andrew D. Beggs [Royaume-Uni] | Appendicular sarcoidosis mimicking acute appendicitis |
| 001353 |
Adam P. Croft [Royaume-Uni] ; Deva Situnayake [Royaume-Uni] ; Omer Khair [Royaume-Uni] ; Gavin Giovanni [Royaume-Uni] ; David Carruthers [Royaume-Uni] ; Arul Sivaguru [Royaume-Uni] ; Caroline Gordon [Royaume-Uni] | Refractory multisystem sarcoidosis responding to infliximab therapy |
| 001394 |
David Keeling [Royaume-Uni] ; Ian Mackie [Royaume-Uni] ; Gary W. Moore [Royaume-Uni] ; Ian A. Greer [Royaume-Uni] ; Michael Greaves [Royaume-Uni] | Guidelines on the investigation and management of antiphospholipid syndrome |
| 001400 |
J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni] | Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients |
| 001402 |
Louise Watson [Royaume-Uni] ; Valentina Leone [Royaume-Uni] ; Clarissa Pilkington [Royaume-Uni] ; Kjell Tullus [Royaume-Uni] ; Satyapal Rangaraj [Royaume-Uni] ; Janet E. Mcdonagh [Royaume-Uni] ; Janet Gardner-Medwin [Royaume-Uni] ; Nick Wilkinson [Royaume-Uni] ; Phil Riley [Royaume-Uni] ; Jane Tizard [Royaume-Uni] ; Kate Armon [Royaume-Uni] ; Manish D. Sinha [Royaume-Uni] ; Yiannis Ioannou [Royaume-Uni] ; Neil Archer [Royaume-Uni] ; Kathryn Bailey [Royaume-Uni] ; Joyce Davidson [Royaume-Uni] ; Eileen M. Baildam [Royaume-Uni] ; Gavin Cleary [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] | Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort |
| 001406 |
Fiona L. Dignan [Royaume-Uni] ; Persis Amrolia [Royaume-Uni] ; Andrew Clark [Royaume-Uni] ; Jacqueline Cornish [Royaume-Uni] ; Graham Jackson [Royaume-Uni] ; Prem Mahendra [Royaume-Uni] ; Julia J. Scarisbrick [Royaume-Uni] ; Peter C. Taylor [Royaume-Uni] ; Bronwen E. Shaw [Royaume-Uni] ; Michael N. Potter [Royaume-Uni] | Diagnosis and management of chronic graft‐versus‐host disease |
| 001411 |
Sengwee Toh [États-Unis] ; Lingling Li [États-Unis] ; Leslie R. Harrold [États-Unis] ; Elizabeth A. Bayliss [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Liyan Liu [États-Unis] ; Lang Chen [États-Unis] ; Carlos G. Grijalva [États-Unis] ; Lisa J. Herrinton [États-Unis] | Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics? |
| 001425 |
David C. Rubinsztein [Royaume-Uni] ; Patrice Codogno [France] ; Beth Levine [États-Unis] | Autophagy modulation as a potential therapeutic target for diverse diseases |
| 001437 |
Luke R. G. Pike [Royaume-Uni] ; Kanchan Phadwal [Royaume-Uni] ; Anna Katharina Simon [Royaume-Uni] ; Adrian L. Harris [Royaume-Uni] | ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia |
| 001481 |
W G Dixon [Royaume-Uni, Canada] ; A. Kezouh [Canada] ; S. Bernatsky [Canada] ; S. Suissa [Canada] | The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study |
| 001484 |
B J Dunmore [Royaume-Uni] ; L. Long [Royaume-Uni] ; X D Yang [Royaume-Uni] ; A. Crosby [Royaume-Uni] ; N W Morrell [Royaume-Uni] | S99 The anti-malarial drug and lysosomal inhibitor, chloroquine, increases cell surface expression of BMPR-II |
| 001486 |
L. Long [Royaume-Uni] ; X. Yang [Royaume-Uni] ; N W Morrell [Royaume-Uni] ; M. Southwood [Royaume-Uni] | S97 BMPR2 R899X knock-in mice developed age-related pulmonary hypertension |
| 001487 |
K. Schreiber [Royaume-Uni] ; O. Ateka-Barrutia [Royaume-Uni] ; Ma Khamashta [Royaume-Uni] ; Grv Hughes [Royaume-Uni] | OBSTETRIC ANTIPHOSPHOLIPID SYNDROME - A REVIEW |
| 001488 |
Kulveer S. Mankia [Royaume-Uni] ; Joel David [Royaume-Uni] | A diagnosis of sarcoid arthritis: ‘check the tattoos’ |
| 001495 |
James E. Peters [Royaume-Uni] ; Christopher J. Burke [Royaume-Uni] ; Vanessa H. Morris [Royaume-Uni] | Three cases of rheumatoid arthritis with laryngeal stridor |
| 001545 |
Guillermo Ruiz-Irastorza [Espagne] ; Munther A. Khamashta [Royaume-Uni] | Lupus and pregnancy: integrating clues from the bench and bedside |
| 001560 |
Muir Morton [Royaume-Uni] ; Sarah Edmonds [Royaume-Uni] ; Aislinn M. Doherty [Royaume-Uni] ; Ajay Dhaygude [Royaume-Uni] ; Matthew Helbert [Royaume-Uni] ; Mike Venning [Royaume-Uni] | Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement |
| 001563 |
Sevda Süzgeç-Selçuk [Turquie] ; Ali H. Meriçli [Turquie] ; Kas M C. Güven [Turquie] ; Marcel Kaiser [Suisse] ; Rosalyn Casey [Royaume-Uni] ; Suzie Hingley-Wilson [Royaume-Uni] ; Ajit Lalvani [Royaume-Uni] ; Deniz Tasdemir [Royaume-Uni] | Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities |
| 001571 |
Amy R. Wyatt [Australie] ; Justin J. Yerbury [Australie] ; Paula Berghofer [Australie] ; Ivan Greguric [Australie] ; Andrew Katsifis [Australie] ; Christopher M. Dobson [Royaume-Uni] ; Mark R. Wilson [Australie] | Clusterin facilitates in vivo clearance of extracellular misfolded proteins |
| 001576 |
Julius Clemence Hafalla [Royaume-Uni, Allemagne] ; Olivier Silvie [Allemagne, France] ; Kai Matuschewski [Allemagne] | Cell biology and immunology of malaria |
| 001589 |
Zaid Zoumot [Royaume-Uni] ; Bhupinder S. Mann [Royaume-Uni] | A severe case of multisystem sarcoidosis complicated by aspergillosis and aspergillomas |
| 001591 |
Adrian Waite [Royaume-Uni] ; Maria Cristina De Rosa [Italie] ; Andrea Brancaccio [Italie] ; Derek J. Blake [Royaume-Uni] | A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway |
| 001643 |
M. Mosca [Italie] ; C. Tani [Italie] ; M. Aringer [Allemagne] ; S. Bombardieri [Italie] ; D. Boumpas [Grèce] ; R. Brey [États-Unis] ; R. Cervera [Espagne] ; A. Doria [Italie] ; D. Jayne [Royaume-Uni] ; M A Khamashta [Royaume-Uni] ; A. Kuhn [Allemagne] ; C. Gordon [Royaume-Uni] ; M. Petri [États-Unis] ; O P Rekvig [Norvège] ; M. Schneider [Allemagne] ; Y. Sherer [Israël] ; Y. Shoenfeld [Israël] ; J S Smolen [Autriche] ; R. Talarico [Italie] ; A. Tincani [Italie] ; R F Van Vollenhoven [Suède] ; M M Ward [États-Unis] ; V P Werth [États-Unis] ; L. Carmona [Espagne] | European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies |
| 001670 |
V. Navaratnam [Royaume-Uni] ; N. Ali [Royaume-Uni] ; Cjp Smith [Royaume-Uni] ; A. Fogarty [Royaume-Uni] ; R B Hubbard [Royaume-Uni] | S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival? |
| 001671 |
R K Coker [Royaume-Uni] ; C. Wang [Royaume-Uni] ; A. Sepahzad [Royaume-Uni] ; N J Roberts [Royaume-Uni] ; M R Partridge [Royaume-Uni] | S54 Characterising sarcoidosis using a web-based registry: a pilot study |
| 001677 |
Tracey E. Toms [Royaume-Uni] ; Jacqueline P. Smith [Royaume-Uni] ; Vasileios F. Panoulas [Royaume-Uni] ; Karen M. J. Douglas [Royaume-Uni] ; Athanasios N. Saratzis [Royaume-Uni] ; George D. Kitas [Royaume-Uni] | Prevalence of risk factors for statin‐induced myopathy in rheumatoid arthritis patients |
| 001691 |
Stephen L. Hart [Royaume-Uni] | Multifunctional nanocomplexes for gene transfer and gene therapy |
| 001692 |
Stephen D. Marks [Royaume-Uni] ; Kjell Tullus [Royaume-Uni] | Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis |
| 001751 |
B. Collin [Royaume-Uni] ; R. Rajaratnam [Royaume-Uni] ; R. Lim [Royaume-Uni] ; H. Lewis [Royaume-Uni] | A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department |
| 001759 |
Elizabeth Stringer [Canada, États-Unis, Royaume-Uni] ; John Bohnsack ; Suzanne L. Bowyer ; Thomas A. Griffin ; Adam M. Huber ; Bianca Lang ; Carol B. Lindsley ; Sylvia Ota ; Clarissa Pilkington ; Ann M. Reed ; Rosie Scuccimarri ; Brian M. Feldman | Treatment Approaches to Juvenile Dermatomyositis (JDM) Across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey |
| 001790 |
Shahir S. Hamdulay [Royaume-Uni] ; Justin C. Mason [Royaume-Uni] | Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA? |
| 001854 |
Natasha Behrendorff [Australie] ; Alka Shukla [Australie] ; Christof Schwiening [Royaume-Uni] ; Peter Thorn [Australie] | Local dynamic changes in confined extracellular environments within organs |
| 001873 |
Ja Reynolds [Royaume-Uni] ; V. Toescu [Royaume-Uni] ; Cs Yee [Royaume-Uni] ; A. Prabu [Royaume-Uni] ; D. Situnayake [Royaume-Uni] ; C. Gordon [Royaume-Uni] | Effects of rituximab on resistant SLE disease including lung involvement |
| 001885 |
Catherine Goodman [Royaume-Uni, Kenya] ; S. Patrick Kachur [États-Unis] ; Salim Abdulla [Tanzanie] ; Peter Bloland [États-Unis] ; Anne Mills [Royaume-Uni] | Concentration and drug prices in the retail market for malaria treatment in rural Tanzania |
| 001900 |
Djalma A. P. Dos Santos [Brésil] ; Patricia A. De C. Braga [Brésil] ; M. Fátima Das G. F. Da Silva [Brésil] ; João B. Fernandes [Brésil] ; Paulo C. Vieira [Brésil] ; Aderbal F. Magalhães [Brésil] ; Eva G. Magalhães [Brésil] ; Anita J. Marsaioli [Brésil] ; Valéria R. De S. Moraes [Brésil] ; Lauren Rattray [Royaume-Uni] ; Simon L. Croft [Royaume-Uni] | Anti‐African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues |
| 001940 |
Adrian Covic [Roumanie] ; Paul Gusbeth-Tatomir [Roumanie] ; David Goldsmith [Royaume-Uni] | Reply |
| 001945 |
Clara J. Day ; Graham W. Lipkin ; Caroline O. S. Savage [Royaume-Uni] | Lupus nephritis and pregnancy in the 21st century |
| 001954 |
Elaine C. Jolly [Royaume-Uni] ; Beverley J. Hunt [Royaume-Uni] ; Spencer Ellis [Royaume-Uni] ; Malcolm Griffiths [Royaume-Uni] ; Ken Farrington [Royaume-Uni] | “Benign” hypergammaglobulinemic purpura is not benign in pregnancy |
| 001959 |
S. Bernatsky [Canada] ; L. Joseph [Canada] ; J-F Boivin [Canada] ; C. Gordon [Canada] ; M. Urowitz [États-Unis] ; D. Gladman [États-Unis] ; P R Fortin [États-Unis] ; E. Ginzler [Corée du Sud] ; S-C Bae [Canada] ; S. Barr [Royaume-Uni] ; S. Edworthy [Royaume-Uni] ; D. Isenberg [États-Unis] ; A. Rahman [États-Unis] ; M. Petri [États-Unis] ; G S Alarc N [États-Unis] ; C. Aranow [États-Unis] ; M-A Dooley [Canada] ; R. Rajan [Canada] ; J-L Sénécal [Canada] ; M. Zummer [États-Unis] ; S. Manzi [États-Unis] ; R. Ramsey-Goldman [Canada, Royaume-Uni, États-Unis, Corée du Sud] ; A E Clarke [Canada] | The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study |
| 001972 |
T Y-T Lu [Royaume-Uni] ; T. Jonsdottir [Suède] ; R F Van Vollenhoven [Suède] ; D A Isenberg [Royaume-Uni] | Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases |
| 001986 |
G. Ruiz-Irastorza [Espagne] ; Ma Khamashta [Royaume-Uni] | Lupus and pregnancy: ten questions and some answers |
| 001A01 |
S. Chambers [Royaume-Uni] ; R. Raine [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; K. Hagley [Jamaïque] ; K. De Ceulaer [Jamaïque] ; D. Isenberg [Royaume-Uni] | Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica |
| 001A09 |
G. Bertsias [Grèce] ; J P A. Ioannidis [Grèce] ; J. Boletis [Grèce] ; S. Bombardieri [Italie] ; R. Cervera [Espagne] ; C. Dostal [République tchèque] ; J. Font [Espagne] ; I M Gilboe [Norvège] ; F. Houssiau [Belgique] ; T. Huizinga [Pays-Bas] ; D. Isenberg [Royaume-Uni] ; C G M. Kallenberg [Pays-Bas] ; M. Khamashta [Royaume-Uni] ; J C Piette [France] ; M. Schneider [Allemagne] ; J. Smolen [Autriche] ; G. Sturfelt [Suède] ; A. Tincani [Italie] ; R. Van Vollenhoven [Suède] ; C. Gordon [Royaume-Uni] ; D T Boumpas [Grèce] | EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics |
| 001A38 |
Shanthi Paramothayan [Royaume-Uni] ; Toby Lasserson [Royaume-Uni] | Treatments for pulmonary sarcoidosis |
| 001A61 |
S. J. Bowman [Royaume-Uni] ; N. Sutcliffe [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] ; F. Goldblatt [Royaume-Uni] ; M. Adler [Royaume-Uni] ; E. Price [Royaume-Uni] ; A. Canavan [Royaume-Uni] ; J. Hamburger [Royaume-Uni] ; A. Richards [Royaume-Uni] ; S. Rauz [Royaume-Uni] ; M. Regan [Royaume-Uni] ; K. Gadsby [Royaume-Uni] ; S. Rigby [Royaume-Uni] ; A. Jones [Royaume-Uni] ; R. Mathew [Royaume-Uni] ; D. Mulherin [Royaume-Uni] ; A. Stevenson [Royaume-Uni] ; P. Nightingale [Royaume-Uni] | Sjögren's Systemic Clinical Activity Index (SCAI)—a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome |
| 001A64 |
David Hilton-Jones [Royaume-Uni] ; Maxwell S. Damian [Royaume-Uni] | Myopathies in the older patient |
| 001A68 |
Nicholas M. Anstey [Australie] ; Tjandra Handojo ; Michael C. F. Pain [Australie] ; Enny Kenangalem [Australie] ; Emiliana Tjitra [Indonésie] ; Ric N. Price [Royaume-Uni] ; Graeme P. Maguire [Australie] | Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar-Capillary Inflammation |
| 001A75 |
Catherine Goodman [Royaume-Uni, Kenya] ; S Patrick Kachur [Tanzanie, États-Unis] ; Salim Abdulla [Tanzanie] ; Peter Bloland [États-Unis] ; Anne Mills [Royaume-Uni] | Drug shop regulation and malaria treatment in Tanzania—why do shops break the rules, and does it matter? |
| 001A81 |
C. M. Everett [Royaume-Uni] ; T. D. Graves [Royaume-Uni] ; S. Lad [Royaume-Uni] ; H. R. J Ger [Royaume-Uni] ; M. Thom [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] ; M. G. Hanna [Royaume-Uni] | Aggressive CNS lupus vasculitis in the absence of systemic disease activity |
| 001A82 |
Laura Price [Royaume-Uni] ; Tim Planche [Royaume-Uni] ; Charlotte Rayner [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] | Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature |
| 001B01 |
Hongmei Gao [Royaume-Uni] ; Susannah K. Leaver [Royaume-Uni] ; Anne Burke-Gaffney [Royaume-Uni] ; Simon J. Finney [Royaume-Uni] | Severe sepsis and Toll-like receptors |
| 001B32 |
R N Jois [Royaume-Uni] ; K. Gaffney [Royaume-Uni] ; P. Cane [Royaume-Uni] ; A G Nicholson [Royaume-Uni] ; A C Wotherspoon [Royaume-Uni] | Methotrexate‐associated lymphoproliferative disorder masquerading as interstitial lung disease |
| 001C26 |
S. Patiar [Royaume-Uni] ; J D Ramsden [Royaume-Uni] ; A P Freeland [Royaume-Uni] | B-cell lymphoma of the larynx in a patient with rheumatoid arthritis |
| 001C34 |
Esha Saha [Royaume-Uni] ; Magdalena Dziadzio [Royaume-Uni, Niger] ; Katherine Irving [Royaume-Uni] ; Anthony Chambers [Royaume-Uni] ; Clare Higgens [Royaume-Uni] | Unusual cause of painful shoulder in an elderly woman with rheumatoid arthritis |
| 001C35 |
A C Cordeiro [Portugal] ; D A Isenberg [Royaume-Uni] | Treatment of inflammatory myopathies |
| 001C71 |
K P Ng [Royaume-Uni] ; M J Leandro [Royaume-Uni] ; J C Edwards [Royaume-Uni] ; M R Ehrenstein [Royaume-Uni] ; G. Cambridge [Royaume-Uni] ; D A Isenberg [Royaume-Uni] | Repeated B cell depletion in treatment of refractory systemic lupus erythematosus |
| 001D07 |
N. B. O'Donoghue [Royaume-Uni] ; R. J. Barlow [Royaume-Uni] | Laser remodelling of nodular nasal lupus pernio |
| 001D10 |
Alison Jordan [Royaume-Uni] ; Janet E. Mcdonagh [Royaume-Uni] | Juvenile idiopathic arthritis: the paediatric perspective |
| 001D17 |
M. N. Lazarus [Royaume-Uni] ; D. Robinson [Royaume-Uni] ; V. Mak [Royaume-Uni] ; H. M Ller [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Incidence of cancer in a cohort of patients with primary Sjögren's syndrome |
| 001D49 |
K M J. Douglas [Royaume-Uni] ; E. Ladoyanni ; G J Treharne [Royaume-Uni] ; E D Hale [Royaume-Uni] ; N. Erb [Royaume-Uni] ; G D Kitas [Royaume-Uni] | Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions |
| 001D88 |
Mark Wood [Royaume-Uni] ; Ruth Wyllie [Royaume-Uni] ; Helen Foster [Royaume-Uni] | A balancing act |
| 001D90 |
Philip J. Hughes [Royaume-Uni] ; Geoffrey Brown [Royaume-Uni] | 1α,25‐dihydroxyvitamin D3‐mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc‐mediated activation of the RAS/RAF/ERK‐MAP kinase signalling pathway |
| 001E20 |
I. N. Bruce [Royaume-Uni] | ‘Not only…but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus |
| 001E35 |
S. I. Chaudhry [Royaume-Uni] ; L. Murphy [Royaume-Uni] ; I. R. White [Royaume-Uni] | Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? |
| 001E42 |
Y. Ioannou [Royaume-Uni] ; S J Bowman [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; I P Giles [Royaume-Uni] | Review of presentations at the 6th European Lupus Meeting 3-5 March 2005 |
| 001E57 |
C. J. Corrigan ; R. J. Shiner [Royaume-Uni] ; B. H. Shakur [Royaume-Uni] ; P. W. Ind [Royaume-Uni] | Methotrexate therapy of oral corticosteroid‐dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy |
| 001E98 |
M. J. Leandro [Royaume-Uni] ; G. Cambridge [Royaume-Uni] ; J. C. Edwards [Royaume-Uni] ; M. R. Ehrenstein [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients |
| 001F03 |
A. Rahman [Royaume-Uni] ; S. J. Bowman [Royaume-Uni] ; I. P. Giles [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Annus mirabilis—a guide to the 6th European Lupus Meeting, 3–5 March 2005 |
| 001F38 |
C. E. Lampropoulos [Royaume-Uni] ; S. Sangle [Royaume-Uni] ; P. Harrison [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni] | Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative |
| 002009 |
J. Ravindran ; N. Shenker ; A. K. Bhalla ; H. Lachmann [Royaume-Uni] ; P. Hawkins [Royaume-Uni] | Case report: response in proteinuria due to AA amyloidosis but not Felty’s syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade |
| 002027 |
P. Jobanputra [Royaume-Uni] ; J. Wilson [Royaume-Uni] ; K. Douglas [Royaume-Uni] ; A. Burls [Royaume-Uni] | A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis |
| 002039 |
Mohga Kamal Smith [Royaume-Uni] ; Sophia Tickell [Royaume-Uni] | The essential drugs concept is needed now more than ever |
| 002048 |
Martin L. Read [Royaume-Uni] ; K. Helen Bremner [Royaume-Uni] ; David Oupick [Royaume-Uni] ; Nicola K. Green [Royaume-Uni] ; Peter F. Searle [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Vectors based on reducible polycations facilitate intracellular release of nucleic acids |
| 002068 |
D. Symmons [Royaume-Uni] | Reply |
| 002106 |
O. Kayser [Allemagne] ; C. Olbrich [Allemagne] ; S. L. Croft [Royaume-Uni] ; A. F. Kiderlen [Allemagne] | Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs |
| 002110 |
N. Porter ; H. L. Beynon [Royaume-Uni] ; H. S. Randeva | Endocrine and reproductive manifestations of sarcoidosis |
| 002124 |
S. L. Nuttall ; S. Heaton [Royaume-Uni] ; M. K. Piper [Royaume-Uni] ; U. Martin ; C. Gordon [Royaume-Uni] | Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia |
| 002125 |
M. Lockshin [États-Unis] ; F. Tenedios [États-Unis] ; M. Petri [États-Unis] ; G. Mccarty [États-Unis] ; R. Forastiero [Argentine] ; S. Krilis [Australie] ; A. Tincani [Italie] ; D. Erkan [États-Unis] ; M A Khamashta [Royaume-Uni] ; Y. Shoenfeld [Israël] | Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report |
| 002199 |
Anita Verma [Royaume-Uni] ; Jim J. Wade [Royaume-Uni] | Non-viral infections of the liver |
| 002205 |
Christopher M. Ward [Royaume-Uni] ; Michal Pechar ; David Oupicky [Royaume-Uni] ; Karel Ulbrich ; Leonard W. Seymour [Royaume-Uni] | Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo |
| 002211 |
H. S. Randeva [Royaume-Uni] ; R. Davison [Royaume-Uni] ; V. Chamoun [Royaume-Uni] ; P. M. G. Bouloux [Royaume-Uni] | Isolated neurosarcoidosis—a diagnostic enigma |
| 002219 |
R. Dinwiddie [Royaume-Uni] ; N. Sharief [Royaume-Uni] ; O. Crawford [Royaume-Uni] | Idiopathic interstitial pneumonitis in children: A national survey in the United Kingdom and Ireland |
| 002257 |
David A. Warrell [Royaume-Uni] | To search and Studdy out the secrett of Tropical Diseases by way of Experiment |
| 002270 |
Colin W. Pouton [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Key issues in non-viral gene delivery |
| 002288 |
P. J. Jost [Royaume-Uni, Allemagne] ; R. P. Harbottle [Royaume-Uni] ; A. Knight [Royaume-Uni] ; A. D. Miller [Royaume-Uni] ; C. Coutelle [Royaume-Uni] ; H. Schneider [Royaume-Uni, Allemagne] | A novel peptide, THALWHT, for the targeting of human airway epithelia |
| 002331 |
S. J. Bowman ; S. Pillemer ; R. Jonsson ; K. Asmussen ; C. Vitali ; R. Manthorpe [Suède] ; N. Sutcliffe [Royaume-Uni] | Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK |
| 002356 |
Stephen Watt-Smith [Royaume-Uni] ; Kuljeet Mehta [Royaume-Uni] ; Crispian Scully [Royaume-Uni] | Mefloquine-induced trigeminal sensory neuropathy |
| 002387 |
Emily S. Scott [Royaume-Uni] ; John W. Wiseman [Royaume-Uni] ; Martin J. Evans [Royaume-Uni] ; William H. Colledge [Royaume-Uni] | Enhanced gene delivery to human airway epithelial cells using an integrin‐targeting lipoplex |
| 002394 |
H. S. Pandha ; Peter Mortimer (dermatologue) [Royaume-Uni] ; B. Souberbeille ; P. Mccoubrie ; M. E. R. O'Brien | Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma |
| 002444 |
Nicholas A. Jones [Royaume-Uni] ; I. R. C Hill [Royaume-Uni] ; Snjezana Stolnik [Royaume-Uni] ; Fabio Bignotti [Italie] ; Stanley S. Davis [Royaume-Uni] ; Martin C. Garnett [Royaume-Uni] | Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer–DNA complexes for gene delivery |
| 002447 |
Ian N. Bruce [Royaume-Uni] ; Dafna D. Gladman ; Murray B. Urowitz | PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 002512 |
M. Eddleston [Royaume-Uni] | Patterns and problems of deliberate self‐poisoning in the developing world |
| 002520 |
S. M. Sultan [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long‐term review |
| 002551 |
Dipen S. Shah [Royaume-Uni] ; T. Sakthivel [Royaume-Uni] ; Istvan Toth [Royaume-Uni] ; Alexander T. Florence [Royaume-Uni] ; Andy F. Wilderspin [Royaume-Uni] | DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers |
| 002562 |
M. Conron [Royaume-Uni] ; C. Young [Royaume-Uni] ; H. L. C. Beynon [Royaume-Uni] | Calcium metabolism in sarcoidosis and its clinical implications |
| 002613 |
Ravinder Maini [Royaume-Uni] ; E William St Clair [États-Unis] ; Ferdinand Breedveld [Pays-Bas] ; Daniel Furst [États-Unis] ; Joachim Kalden [Allemagne] ; Michael Weisman [États-Unis] ; Josef Smolen [Autriche] ; Paul Emery [Royaume-Uni] ; Gregory Harriman [États-Unis] ; Marc Feldmann [Royaume-Uni] ; Peter Lipsky [États-Unis] | Infliximab (chimeric anti-tumour necrosis factor monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial |
| 002631 |
Anne Kobza Black [Royaume-Uni] | Urticarial vasculitis |
| 002642 |
Charles J. Woodrow [Royaume-Uni] ; Isabela Riberio [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] | Recent developments in the management of malaria |
| 002676 |
P. R. Smith ; D. D'Cruz ; M. J. Raftery ; S. M. Dodd ; M. Helbert [Royaume-Uni] ; C. J. Skinner | Drug-induced lupus nephritis in HIV infection |
| 002687 |
J. P. Zajicek ; N. J. Scolding ; O. Foster ; M. Rovaris ; J. Evanson ; I. F. Moseley ; J. W. Scadding ; E. J. Thompson ; V. Chamoun ; D. H. Miller ; W. I. Mcdonald ; D. Mitchell [Royaume-Uni] | Central nervous system sarcoidosis—diagnosis and management |
| 002693 |
Millard [Royaume-Uni] ; Smith [Royaume-Uni] ; Black [Royaume-Uni] ; Barker [Royaume-Uni] | Bullous pemphigoid developing during systemic therapy with chloroquine |
| 002694 |
Jill P. Buyon [États-Unis] ; Kenneth C. Kalunian [États-Unis] ; Rosalind Ramsey-Goldman [États-Unis] ; Michelle A. Petri ; Michael D. Lockshin [États-Unis] ; Guillermo Ruiz-Irastorza ; Munther Khamashta [Royaume-Uni] | Assessing disease activity in SLE patients during pregnancy |
| 002703 |
S. M. Sultan [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | A review of gastrointestinal manifestations of systemic lupus erythematosus |
| 002733 |
S. Pukrittayakamee [Thaïlande] ; A. Chantra [Thaïlande] ; S. Vanijanonta [Thaïlande] ; N. J. White [Thaïlande, Royaume-Uni] | Pulmonary oedema in vivax malaria |
| 002743 |
Ab Kay [Royaume-Uni] ; Nc Barnes [Royaume-Uni] | Non-steroidal anti-inflammatory therapy for asthma |
| 002752 |
Colin W. Pouton [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Key issues in non-viral gene delivery |
| 002787 |
A G Nicholson ; H. Kim [Corée du Sud] ; B. Corrin ; A. Bush [Royaume-Uni] ; R M Du Bois [Royaume-Uni] ; M. Rosenthal [Royaume-Uni] ; M N Sheppard | The value of classifying interstitial pneumonitis in childhood according to defined histological patterns |
| 002835 |
Farrell ; Moss [Royaume-Uni] ; Costello ; Fearfield ; Woodrow ; Bunker | Benign cutaneous Degos' disease |
| 002849 |
K. Barnes [Royaume-Uni] ; C. Brown [Royaume-Uni] ; A. J. Turner [Royaume-Uni] | Endothelin-converting enzyme : Ultrastructural localization and its recycling from the cell surface |
| 002878 |
Melissa Wickremasinghe [Royaume-Uni] ; Jon S. Friedland [Royaume-Uni] | Mycobacterium tuberculosis stimulates transcription-dependent chemokine secretion from human respiratory epithelial cells |
| 002978 |
Neil Rayment [Royaume-Uni] ; Robert F. Miller [Royaume-Uni] ; Nabeel Ali [Royaume-Uni] ; Michael H. Binks [Royaume-Uni] ; David R. Katz [Royaume-Uni] | Synthesis of Tumor Necrosis Factor-α mRNA in Bronchoalveolar Lavage Cells from Human Immunodeficiency Virus-Infected Persons with Pneumocystis carinii Pneumonia |
| 002A06 |
Okezie I. Aruoma [Royaume-Uni] | Characterization of drugs as antioxidant prophylactics |
| 002A47 |
Andrew Bush [Royaume-Uni] | Diagnosis of interstitial lung disease |
| 002A48 |
T. W. Beer [Royaume-Uni] ; D. C. Rowlands [Royaume-Uni] ; J. Crocker [Royaume-Uni] | Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours. |
| 002A72 |
L M Andersson [Royaume-Uni] ; M J Warburton | Intracellular degradation of type I collagen and fibronectin in human lung fibroblasts: evidence against degradation in pre-lysosomal compartments. |
| 002A90 |
Sheena Mitchell [Royaume-Uni] | Neuropathies |
| 002A91 |
David Hilton-Jones [Royaume-Uni] | Myopathies |
| 002B23 |
L. B. Tucker [États-Unis] ; S. Menon [Royaume-Uni] ; J. G. Schaller [États-Unis] ; D. A. Isenberg [Royaume-Uni] | ADULT- AND CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARISON OF ONSET, CLINICAL FEATURES, SEROLOGY, AND OUTCOME |
| 002B42 |
Caroline Gordon [Royaume-Uni] | Rheumatic diseases in pregnancy |
| 002B63 |
Michael J. Davies [Royaume-Uni] ; Saify S. Arsiwala [Royaume-Uni] ; Hillary M. Moore [Royaume-Uni] ; Steven Kerr [Royaume-Uni] ; Andrezej W. Sosnowski [Royaume-Uni] ; Richard K. Firmin [Royaume-Uni] | Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism |
| 002B71 |
Jacqueline Guy [Royaume-Uni] ; Dubravka Drabek [Royaume-Uni] ; Michael Antoniou [Royaume-Uni] | Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy |
| 002C23 |
Jim Egan [Royaume-Uni] ; James Stewart [Royaume-Uni] ; Nizar Yonan [Royaume-Uni] ; John Arrand [Royaume-Uni] ; Ashley Woodcock [Royaume-Uni] ; Dietrich Peest [Allemagne] ; Helmuth Deicher [Allemagne] | Non-Hodgkin lymphoma in heart/lung transplant recipients |
| 002C84 |
N. Sharief [Royaume-Uni] ; O. F. Crawford [Royaume-Uni] ; R. Dinwiddie [Royaume-Uni] | Fibrosing alveolitis and desquamative interstitial pneumonitis |
| 002C87 |
Bridget T. Hill [Royaume-Uni] ; Louise K. Hosking [France] | Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance |
| 002D18 |
R. M. Ekong [Royaume-Uni] ; K. J. H. Robson ; D. A. Baker ; D. C. Warhurst | Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum |
| 002D22 |
C P Conlon [Royaume-Uni] | The immunocompromised traveller |
| 002D24 |
G. G. Colle [Royaume-Uni] ; G. C. Hanson | THE MANAGEMENT OF ACUTE POISONING |
| 002D33 |
Neil Mm Buchanan [Royaume-Uni] ; Munther Khamashta [Royaume-Uni] ; Sian Kerslake [Royaume-Uni] ; Beverley J Hunt [Royaume-Uni] ; Graham Rv Hughes [Royaume-Uni] | Practical management of pregnancy in systemic lupus erythematosus |
| 002D70 |
A. A. Borg [Royaume-Uni] ; C. Wynn-Jones [Royaume-Uni] ; P. T. Dawes [Royaume-Uni] | Synovial sarcoma manifesting as a single joint flare in rheumatoid arthritis |
| 002D84 |
S. Tariq [Royaume-Uni] ; S. M. Tariq [Royaume-Uni] | Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent? |
| 002D96 |
J. R. Mcpeake [Royaume-Uni] ; W. J. R. Hirst [Royaume-Uni] ; A. M. Brind [Royaume-Uni] ; Roger Williams [Royaume-Uni] | Hepatitis A causing a second episode of virus–associated haemophagoeytic lymphohistiocytosis in a patient with Still's disease |
| 002E68 |
G. C. Cook [Royaume-Uni] | Malaria: an underdiagnosed and often neglected medical emergency |
| 002E70 |
D. Geraint James [Royaume-Uni] | Lupus Pernio |
| 002E85 |
Howard Bird [Royaume-Uni] | Author's reply |
| 002E94 |
D A Spencer [Royaume-Uni] ; J F Price | A case of fibrosing alveolitis in childhood. |
| 002E97 |
Ronald A. Asherson [Royaume-Uni] ; David D'Cruz [Royaume-Uni] ; Catherine J. M. Stephens [Royaume-Uni] ; Phillip H. Mckee [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] | Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment |
| 002F21 |
David Hilton-Jones [Royaume-Uni] | Myopathies |
| 002F43 |
A. E. Wakefield [Royaume-Uni] ; L. Guiver [Royaume-Uni] ; R. F. Miller [Royaume-Uni] ; J. M. Hopkin [Royaume-Uni] | DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia |
| 002F53 |
G. C. Cook [Royaume-Uni] | Tropical medicine. |
| 002F54 |
R A Asherson [Royaume-Uni] ; H. Angus [Royaume-Uni] ; J A Mathews [Royaume-Uni] ; O. Meyers [Royaume-Uni] ; G R Hughes [Royaume-Uni] | The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression. |
| 002F60 |
R. A. Asherson [Royaume-Uni] ; R. Cervera [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni] ; G. R. Hughes [Royaume-Uni] | Rheumatology. |
| 002F90 |
C. B. Bunker [Royaume-Uni] ; J. J. H. Gilkes [Royaume-Uni] | (52) Granulomatous cheilitis and Crohn's disease |
| 002F91 |
H. Baker [Royaume-Uni] ; I. M. Leigh [Royaume-Uni] ; C. M. Proby [Royaume-Uni] | (51) Sarcoidosis with severe dactylitis and acral calcinosis |
| 002F92 |
J. M. Mcgregor [Royaume-Uni] ; D. M. Macdonald [Royaume-Uni] | (44) Calcinosis cutis in polymyositis‐scleroderma (Pm‐ScI) overlap syndrome |
| 002F93 |
L. Ostlere [Royaume-Uni] ; D. Harris [Royaume-Uni] ; C. Buckley [Royaume-Uni] ; C. Black [Royaume-Uni] ; M. H. A. Rustin [Royaume-Uni] | (43) Atypical systemic sclerosis following exposure to polyvinyl chloride monomer |
| 002F94 |
P. C. Goldsmith [Royaume-Uni] ; M. Dowd [Royaume-Uni] | (42) Morphoea and mononeuritis multiplex |
| 002F95 |
S. C. Mayou [Royaume-Uni] ; D. D. Munro [Royaume-Uni] | (41) Discoid lupus erythematosus in vitiligo |
| 002F99 |
Catherine Hill [Royaume-Uni] ; Ellen Benhamou [Royaume-Uni] ; Françoise Doyon [Royaume-Uni] ; Stanc Freni [États-Unis] ; Devra Lee Davis [États-Unis] ; David Hoel [Royaume-Uni] ; John Fox [Royaume-Uni] ; Alan Lopez [Suisse] | Trends in cancer mortality |
| 003052 |
Christian P. L. Lewis [Royaume-Uni] ; Gerald M. Cohen [Royaume-Uni] ; Lewis L. Smith [Royaume-Uni] | The identification and characterization of an uptake system for taurine into rat lung slices |
| 003071 |
H. A. Bird [Royaume-Uni] | Medical Treatment for Rheumatic Diseases |
| 003228 |
G. Bou-Gharios [Royaume-Uni] ; J. Moss [Royaume-Uni] ; I. Olsen [Royaume-Uni] ; T. Partridge [Royaume-Uni] | Ultrastructural localization of a lysosomal enzyme in resin-embedded lymphocytes |
| 003240 |
A. C. Davidson [Royaume-Uni] ; C. Bateman [Royaume-Uni] ; C. Shovlin [Royaume-Uni] ; M. Marrinan [Royaume-Uni] ; G. H. Burton [Royaume-Uni] ; I. R. Cameron [Royaume-Uni] | Pulmonary toxicity of malaria prophylaxis. |
| 003258 |
Julian L. Allen [États-Unis] ; Oommen P. Mathew [États-Unis] ; Peter Macfarlane [Royaume-Uni] ; David Heaf [Royaume-Uni] ; Hans Pasterkamp [Canada] ; Asher Tal [Israël] ; Micha Aviram [Israël] | Correspondence |
| 003261 |
Frederic R. Costa-Jussà [Royaume-Uni] ; Ana Guevara ; Gary A. Brook [Royaume-Uni] ; Leo W. Duchen [Royaume-Uni] ; Jean M. Jacobs [Royaume-Uni] | Changes in denervated skeletal muscle of amiodarone‐fed mice |
| 003264 |
C G Mackworth-Young [Royaume-Uni] ; J. David [Royaume-Uni] ; S H Morgan [Royaume-Uni] ; G R Hughes [Royaume-Uni] | A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus. |
| 003267 |
C. B. Bunker [Royaume-Uni] ; P. D. L. Maurice [Royaume-Uni] ; J. C. Sharp [Royaume-Uni] ; A. W. P. Du Vivier [Royaume-Uni] ; Pauline M. Dowd [Royaume-Uni] | (12) Scleroderma and polymyositis overlap syndrome associated with IgG lambda paraproteinaemia and cutaneous amyloid deposition |
| 003283 |
Jeremyk Nicholson [Royaume-Uni] ; Felicity Nicholson [Royaume-Uni] | PROTON SPECTROSCOPY OF PLASMA AND TESTING FOR MALIGNANCY |
| 003295 |
Sornchai Looareesuwan [Thaïlande] ; Nicholasj. White [Thaïlande, Royaume-Uni] ; Danai Bunnag [Thaïlande] ; Sunee Chittamas [Thaïlande] ; Tranakchit Harinasuta [Thaïlande] | HIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND |
| 003480 |
R. M. Buchdahl [Royaume-Uni] ; P. Taylor [Royaume-Uni] ; J. O. Warner [Royaume-Uni] | NEBULISED RIBAVIRIN FOR ADENOVIRUS PNEUMONIA |
| 003506 |
M. F. Heath [Royaume-Uni] ; W. Jacobson [Royaume-Uni] | The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant |
| 003555 |
R. A. Wilson [Royaume-Uni] ; P. S. Coulson [Royaume-Uni] | The effect of soft-wood sawdust bedding on the maturation of an infection of Schistosoma mansoni in mice exposed to cercariae via the tail or abdominal skin |
| 003563 |
John Rees [Royaume-Uni] ; Wyn Davies [Royaume-Uni] ; Paul Curry [Royaume-Uni] | MYOCARDIAL OXYGEN CONSUMPTION OR AVAILABILITY |
| 003568 |
R. Million [Royaume-Uni] ; P. Poole [Royaume-Uni] ; J. H. Kellgren [Royaume-Uni] ; M. I. V. Jayson [Royaume-Uni] | LONG-TERM STUDY OF MANAGEMENT OF RHEUMATOID ARTHRITIS |
| 003615 |
F. R. Costa-Jussà [Royaume-Uni] ; B. Corrin [Royaume-Uni] ; J. M. Jacobs [Royaume-Uni] | Amiodarone lung toxicity: A human and experimental study |
| 003632 |
V. M. Novelli [Royaume-Uni] ; W. C. Marshall [Royaume-Uni] ; W. Hendrickse [Royaume-Uni] ; M. Levin [Royaume-Uni] ; J. Smallhorn [Royaume-Uni] ; A. Gailbraith [Royaume-Uni] ; G. Cherian [Royaume-Uni] ; E. J. Moynahan [Royaume-Uni] | KAWASAKI DISEASE IN LONDON |
| 003642 |
D. T. Hughes [Royaume-Uni] ; N. Cavanagh [Royaume-Uni] | CHROMOSOMAL STUDIES ON CHILDREN WITH PHOCOMELIA, EXPOSED TO DEBENDOX DURING EARLY PREGNANCY |
| 003686 |
David B. A. Hutchinson [Royaume-Uni] ; Jennifer A. Farquhar [Royaume-Uni] | Trimethoprim-Sulfamethoxazole in the Treatment of Malaria, Toxoplasmosis, and Pediculosis |
| 003687 |
D. Mitrovic [France] ; E. Mccall [France, Royaume-Uni] ; F. Dray [France] | The in vitro production of prostanoids by cultured bovine articular chondrocytes |
| 003695 |
Adrian J. Salter [Royaume-Uni] | Overview. Trimethoprim-Sulfamethoxazole: An Assessment of More Than 12 Years of Use |
| 003703 |
Maurice Super [Royaume-Uni] ; Elizabethm. Summers [Royaume-Uni] ; A. D. Milner [Royaume-Uni] ; H. Vyas [Royaume-Uni] | HAZARDS OF AMNIOCENTESIS |
| 003708 |
Joan R. Rest [Royaume-Uni] | Cerebral malaria in inbred mice. I. A new model and its pathology |
| 003714 |
W. Peters [Royaume-Uni] | ANTIMALARIAL DRUG RESISTANCE: AN INCREASING PROBLEM |
| 003720 |
David Scott [Royaume-Uni] ; David Scott [Royaume-Uni] ; Paul Bacon [Royaume-Uni] | THERAPEUTIC PROGRESS—REVIEW VITREATMENT OF RHEUMATOID ARTHRITIS |
| 003736 |
D. A. Isenberg [Royaume-Uni] ; A. Tookman [Royaume-Uni] ; A. G. White [Royaume-Uni] ; B. I. Hoffbrand [Royaume-Uni] ; J. Mowbray [Royaume-Uni] | Erosive rheumatoid arthritis co-existing with systemic lupus erythematosus. A report of a case, also showing atlanto-axial subluxation |
| 003772 |
John Dobbing [Royaume-Uni] | FALTERING GROWTH AND HUMAN MILK |
| 003779 |
T. R. Littler [Royaume-Uni] | Anti-rheumatic drugs |
| 003809 |
M. N. Eakins [Royaume-Uni] ; R. W. Goulding [Royaume-Uni] ; S. Somaia [Royaume-Uni] | The distribution and metabolism in the rat of a short series of 4-amino-7-iodoquinolines labelled with radioiodine |
| 003810 |
Richard Knight [Royaume-Uni] | The chemotherapy of amoebiasis |
| 003836 |
A. P. Hall [Royaume-Uni] | Malaria |
| 003866 |
R. Bell [Royaume-Uni] ; D. S. Lawrence [Royaume-Uni] | Chronic pleurisy in systemic lupus erythematosus treated with pleurectomy |
| 003867 |
L. J. Bruce-Chwatt [Royaume-Uni] ; Wallace Peters [Royaume-Uni] | CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM IN AFRICA |
| 003875 |
Philip V. Harrison [Royaume-Uni] | THE ANNULAR ERYTHEMAS |
| 003883 |
A. K. Pain [Royaume-Uni] ; G. Donald [Royaume-Uni] ; W. Mckendrick [Royaume-Uni] | Indigenous amoebic liver abscess |
| 003952 |
Alan Blackham [Royaume-Uni] ; Henryk Radziwonik [Royaume-Uni] | The effect of drugs in established rabbit monoarticular arthritis |
| 003964 |
M. N. Moore [Royaume-Uni] ; A. R. D. Stebbing [Royaume-Uni] | The quantitative cytochemical effects of three metal ions on a lysosomal hydrolase of a hydroid |
| 003990 |
E. Neville [Royaume-Uni] ; R. G. S. Mills [Royaume-Uni] ; D. G. James [Royaume-Uni] | SARCOIDOSIS OF THE UPPER RESPIRATORY TRACT AND ITS RELATION TO LUPUS PERNIO |
| 003996 |
A. J. Barson [Royaume-Uni] ; R. H. A. Campbell [Royaume-Uni] ; F. A. Langley [Royaume-Uni] ; R. D. G. Milner [Royaume-Uni] | Idiopathic arterial calcification of infancy without intimal proliferation |
| 003A02 |
D. Geraint James [Royaume-Uni] ; Edmund Neville [Royaume-Uni] ; L. S. Carstairs [Royaume-Uni] | Bone and joint sarcoidosis |
| 003A03 |
E. Neville [Royaume-Uni] ; L. S. Carstairs [Royaume-Uni] ; D. G. James [Royaume-Uni] | BONE SARCOIDOSIS |
| 003A30 |
Alan Blackham [Royaume-Uni] ; Henryk Radziwonik [Royaume-Uni] ; Ian H. Shaw [Royaume-Uni] | The Arthus reaction in guinea-pig knee joints. A test for anti-inflammatory drugs |
| 003A69 |
David Cade [Royaume-Uni] ; G. D. Webster | Amoebic perforation of the intestine in children |
| 003A73 |
N. R. Rowell [Royaume-Uni] | A painful bleeding syndrome associated with increased fibrinolytic activity |
| 003B54 |
J. Trevor Hughes [Royaume-Uni] ; Margaret Esiri [Royaume-Uni] ; J. M. Oxbury [Royaume-Uni] ; C. W. M. Whitty [Royaume-Uni] | Chloroquine Myopathy |
| 003C33 |
N. L. Browse [Royaume-Uni] ; J. H. Hall [Royaume-Uni] | EFFECT OF DIPYRIDAMOLE ON THE INCIDENCE OF CLINICALLY DETECTABLE DEEP-VEIN THROMBOSIS |
| 003C67 |
R. J. Kellett [Royaume-Uni] ; G. O. Cowan [Royaume-Uni] ; E. S. Parry [Royaume-Uni] | CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA IN THE UNITED KINGDOM |
| 003C95 |
H. A. K. Rowland [Royaume-Uni] | Amoebiasis in freetown, Sierra Leone |
| 003D35 |
I. F. Skidmore [Royaume-Uni] ; M. W. Whitehouse | Concerning the regulation of some diverse biochemical reactions underlying the inflammatory response by salicylic acid, phenylbutazone and other acidic antirheumatic drugs |
| 003D50 |
Frank Hawking [Royaume-Uni] | Advances in filariasis especially concerning periodicity of microfilariae |
| 003D60 |
R. A. Dalley [Royaume-Uni] ; D. Hainsworth [Royaume-Uni] | Fatal Plaquenil Poisoning |
| 003E21 |
D. A. H. Yates [Royaume-Uni] | CAVITATION OF A RHEUMATOID LUNG NODULE |
| 003E25 |
H. O. J. Collier [Royaume-Uni] | THE ACTION AND ANTAGONISM OF KININS ON BRONCHIOLES |
| 003E87 |
A. H. T. Robb-Smith [Royaume-Uni] | ATHEROSCLEROSIS AND CORONARY HEART-DISEASE |
| 003E89 |
W. G. Spector [Royaume-Uni] ; D. A. Willoughby [Royaume-Uni] | The suppression by anti‐esterases of increased capillary permeability in acute inflammation |
| 003F23 |
Niilo K Rki [Royaume-Uni] ; Georgep. Burn [Royaume-Uni] ; J. H. Burn [Royaume-Uni] | THE EFFECT OF QUINIDINE ON POTASSIUM FLUX |
| 003F25 |
H. Gaylis [Royaume-Uni] | Thromboangiitis Obliterans in a Female |
| 003F26 |
C. D. Calnan [Royaume-Uni] | LYMPHOCYTIC INFILTRATION OF THE SKIN (JESSNER). |
| 003F34 |
Joseph Luder [Royaume-Uni] | THE DIARRHOEA AND VOMITING SYNDROME IN AFRICAN CHILDREN IN UGANDA |
| 003F72 |
D. G. Davey [Royaume-Uni] | CHEMOTHERAPY OF MALARIA |
